Muzaffar Abbas

526 total citations
29 papers, 392 citations indexed

About

Muzaffar Abbas is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Muzaffar Abbas has authored 29 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in Muzaffar Abbas's work include Pain Mechanisms and Treatments (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Neuropeptides and Animal Physiology (5 papers). Muzaffar Abbas is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Neuropeptides and Animal Physiology (5 papers). Muzaffar Abbas collaborates with scholars based in Pakistan, United States and China. Muzaffar Abbas's co-authors include Shafiqur Rahman, Fazal Subhan, Sami I. Alzarea, Humaira Nadeem, Khalid Rauf, Roger L. Papke, Gowhar Ali, Lina T. Al Kury, Fawad Ali Shah and Arif‐ullah Khan and has published in prestigious journals such as International Journal of Molecular Sciences, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Muzaffar Abbas

28 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muzaffar Abbas Pakistan 14 132 85 81 75 60 29 392
Madhu Kaundal India 11 155 1.2× 142 1.7× 76 0.9× 102 1.4× 46 0.8× 15 415
Yea-Hyun Leem South Korea 15 170 1.3× 111 1.3× 78 1.0× 77 1.0× 89 1.5× 16 430
Cristiane Signor Brazil 13 143 1.1× 116 1.4× 64 0.8× 141 1.9× 78 1.3× 17 473
Yong‐Hyun Ko South Korea 15 145 1.1× 54 0.6× 48 0.6× 85 1.1× 120 2.0× 26 407
Haibiao Guo China 12 238 1.8× 82 1.0× 85 1.0× 103 1.4× 43 0.7× 19 431
Patricia C. Marisco Brazil 8 78 0.6× 87 1.0× 55 0.7× 111 1.5× 51 0.8× 8 354
Shinichi Uchida Japan 13 228 1.7× 137 1.6× 71 0.9× 54 0.7× 71 1.2× 23 623
Ahmad Tarmizi Che Has Malaysia 9 179 1.4× 74 0.9× 71 0.9× 36 0.5× 121 2.0× 22 492
Kushal Kumar India 10 163 1.2× 97 1.1× 54 0.7× 82 1.1× 112 1.9× 11 421

Countries citing papers authored by Muzaffar Abbas

Since Specialization
Citations

This map shows the geographic impact of Muzaffar Abbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffar Abbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffar Abbas more than expected).

Fields of papers citing papers by Muzaffar Abbas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffar Abbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffar Abbas. The network helps show where Muzaffar Abbas may publish in the future.

Co-authorship network of co-authors of Muzaffar Abbas

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffar Abbas. A scholar is included among the top collaborators of Muzaffar Abbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffar Abbas. Muzaffar Abbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hussain, Hidayat, et al.. (2022). Frankincense diterpenes as a bio-source for drug discovery. Expert Opinion on Drug Discovery. 17(5). 513–529. 15 indexed citations
3.
Abbas, Muzaffar, Lina T. Al Kury, Fawad Ali Shah, et al.. (2021). Thiazolidine Derivatives Attenuate Carrageenan-Induced Inflammatory Pain in Mice. Drug Design Development and Therapy. Volume 15. 369–384. 8 indexed citations
4.
Abbas, Muzaffar, et al.. (2020). A Novel Sulfonamide, 4-FS, Reduces Ethanol Drinking and Physical Withdrawal Associated With Ethanol Dependence. International Journal of Molecular Sciences. 21(12). 4411–4411. 3 indexed citations
5.
Esmaeilpour, Khadijeh, et al.. (2020). Effect of 4-Fluoro-N-(4-sulfamoylbenzyl) Benzene Sulfonamide on cognitive deficits and hippocampal plasticity during nicotine withdrawal in rats. Biomedicine & Pharmacotherapy. 131. 110783–110783. 7 indexed citations
6.
Abbas, Muzaffar, et al.. (2020). <p>Analgesic and Antiallodynic Effects of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide in a Murine Model of Pain</p>. Drug Design Development and Therapy. Volume 14. 4511–4518. 4 indexed citations
7.
Abbas, Muzaffar, et al.. (2020). <p>Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels</p>. Drug Design Development and Therapy. Volume 14. 3777–3786. 6 indexed citations
8.
Abbas, Muzaffar, Sami I. Alzarea, Roger L. Papke, & Shafiqur Rahman. (2019). The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice. Pharmacological Reports. 71(6). 1168–1176. 18 indexed citations
9.
Shah, Fawad Ali, Gong‐Ping Liu, Lina T. Al Kury, et al.. (2019). Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways. Frontiers in Pharmacology. 10. 297–297. 46 indexed citations
10.
Nadeem, Humaira, et al.. (2019). Synthesis and anti-nociceptive potential of isoxazole carboxamide derivatives. BMC Chemistry. 13(1). 6–6. 18 indexed citations
11.
12.
Abbas, Muzaffar & Shafiqur Rahman. (2016). Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice. European Journal of Pharmacology. 783. 85–91. 20 indexed citations
13.
Islam, Nazrul, Muzaffar Abbas, & Shafiqur Rahman. (2016). Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy. CNS & Neurological Disorders - Drug Targets. 16(3). 303–310. 5 indexed citations
14.
Ali, Gowhar, et al.. (2015). A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(11). 1129–1140. 44 indexed citations
15.
Khan, Munasib, Fazal Subhan, Arif‐ullah Khan, et al.. (2013). Nature cures nature: Hypericum perforatum attenuates physical withdrawal signs in opium dependent rats. Pharmaceutical Biology. 52(5). 586–590. 4 indexed citations
16.
Ali, Gowhar, Khalid Rauf, Nazar Ul Islam, et al.. (2012). Input of Isosteric and Bioisosteric Approach in Drug design. Journal of the chemical society of pakistan. 36(1). 150–169. 5 indexed citations
17.
Rauf, Khalid, et al.. (2012). Effect of acute and sub chronic use of Bacopa monnieri on dopamine and serotonin turnover in mice whole brain. African Journal of Pharmacy and Pharmacology. 6(39). 2767–2774. 14 indexed citations
18.
Khan, Haroon, Muhammad Saeed, Anwarul Hassan Gilani, et al.. (2012). Bronchodilator Activity of Aerial Parts of Polygonatum verticillatum Augmented by Anti‐inflammatory Activity: Attenuation of Ca2+ Channels and Lipoxygenase. Phytotherapy Research. 27(9). 1288–1292. 15 indexed citations
19.
Abbas, Muzaffar, et al.. (2011). The involvement of opioidergic mechanisms in the activity of Bacopa monnieriextract and its toxicological studies. African Journal of Pharmacy and Pharmacology. 5(8). 1120–1124. 15 indexed citations
20.
Rauf, Khalid, Fazal Subhan, Muzaffar Abbas, et al.. (2011). Effect of Bacopasides on acquisition and expression of morphine tolerance. Phytomedicine. 18(10). 836–842. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madhu Kaundal Breakdown of academic impact, for papers by Yea-Hyun Leem Breakdown of academic impact, for papers by Cristiane Signor Breakdown of academic impact, for papers by Yong‐Hyun Ko Breakdown of academic impact, for papers by Haibiao Guo Breakdown of academic impact, for papers by Patricia C. Marisco Breakdown of academic impact, for papers by Shinichi Uchida Breakdown of academic impact, for papers by Ahmad Tarmizi Che Has Breakdown of academic impact, for papers by Kushal Kumar
Rankless by CCL
2026